Hosted on MSN1d
Scientists develop worlds-first universal gene therapy for anemia
Diamond-Blackfan anemia (DBA) is a rare, life-threatening genetic blood ... Stem cell transplants, the only potential cure, ...
The First Crispr Treatment Is Making Its Way to Patients
It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.
Medscape2d
Mechanisms and Treatment of Anemia in Chronic Heart Failure
Anemia is highly prevalent in patients with chronic heart failure (HF) and is associated with poor clinical outcomes. Multiple mechanisms contribute to anemia in chronic HF, and subnormal ...
Future Market Insights2d
Global Chemotherapy-Induced Anemia Market Set to Reach USD 4.3 Billion by 2032, Driven by Advancements and Growing Government Initiatives | FMI
Anemia, a condition characterized by a reduction in red blood cells or hemoglobin, limits oxygen transport within the body.
Everyday Health7d
Sickle Cell Anemia Treatment: A Complete Guide
Sickle cell anemia requires ongoing, lifelong treatment to improve quality of life and prevent complications. Treatment of sickle cell anemia includes taking measures to treat anemia, prevent ...
Daily1d
GSK Ojjaara approved in Canada for treatment of myelofibrosis in adults who have moderate to severe anemia
Mississauga: GSK has announced that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or ...
Targeted Oncology11d
Future Perspective on Anemia Treatment in LR-MDS
Saeed Sadeghi, MD, explores the future treatment landscape for anemia in lower-risk myelodysplastic syndromes (LR-MDS), ...
Medindia4d
Ojjaara (momelotinib) approved in Canada for the treatment of myelofibrosis in adults who have moderate to severe anemia
Canada NewsWire MISSISSAUGA, ON, Nov. 12, 2024 MISSISSAUGA, ON, Nov. 12, 2024 /CNW/ - GSK announced today that Health Canada has approved Ojjaara (momelotinib) for the treatment o ...